|1.||Tamori, Akihiro: 3 articles (01/2014 - 01/2012)|
|2.||Nakamura, Yusuke: 3 articles (07/2011 - 05/2009)|
|3.||Kumada, Hiromitsu: 2 articles (04/2015 - 05/2009)|
|4.||Seto, Wai-Kay: 2 articles (03/2014 - 01/2014)|
|5.||Yuen, Man-Fung: 2 articles (03/2014 - 01/2014)|
|6.||Kurosaki, Masayuki: 2 articles (01/2014 - 01/2012)|
|7.||Tanaka, Eiji: 2 articles (01/2014 - 01/2012)|
|8.||Hino, Keisuke: 2 articles (01/2014 - 01/2012)|
|9.||Matsuura, Kentaro: 2 articles (01/2014 - 01/2012)|
|10.||Tokunaga, Katsushi: 2 articles (01/2014 - 01/2012)|
03/01/2014 - "We compared the SNPs in the HLA-DPA1 gene (rs3077) and the IFN-γ receptor-2 gene (rs2284553 and rs9808753) of 100 treatment-naive hepatitis B e antigen (HBeAg)-negative CHB patients with undetectable HBV DNA with 100 age- and sex-matched controls with HBV DNA > 2000 IU/mL. The median age of the study group was 47.9 years, and 61% were male patients. "
09/01/2014 - "Four SNPs among the HLA-DPA1, HLA-DPB1 (rs3077 and rs9277535) and IL28B (rs12979860 and rs8099917) regions were genotyped using the MGB-TaqMan SNP genotyping assay in 144 hepatitis B e-antigen (HBeAg) seropositive CHB patients who had received 6-12 months IFN-α or PEG IFN treatment. "
04/01/2015 - "Japanese patients (202) who were hepatitis B e antigen positive at baseline, received LAM as first-line treatment, and consented to HLA-DP genotyping (HLA-DPA1 rs3077 and HLA-DPB1 rs9277535) were categorized into two cohorts, viz., a cohort who achieved virological response without rescue therapy (cohort 1) and those who did so with rescue therapy (cohort 2). "
|2.||Chronic Hepatitis B
01/01/2012 - "We also found that the HLA-DPA1 and HLA-DPB1 genes were significantly associated with protective effects against chronic hepatitis B (CHB) in Japanese, Korean and other Asian populations, including Chinese and Thai individuals (P(meta) = 4.40×10⁻¹⁹ for rs3077 and P(meta) = 1.28×10⁻¹⁵ for rs9277542). "
05/01/2009 - "Through a two-stage genome-wide association study using 786 Japanese chronic hepatitis B cases and 2,201 controls, we identified a significant association of chronic hepatitis B with 11 SNPs in a region including HLA-DPA1 and HLA-DPB1. "
09/01/2011 - "We conclude that the variants previously associated with chronic hepatitis B are also strongly associated with mRNA expression of HLA-DPA1 and HLA-DPB1, suggesting that expression of these genes is important in control of HBV."
09/01/2011 - "Risk alleles for chronic hepatitis B are associated with decreased mRNA expression of HLA-DPA1 and HLA-DPB1 in normal human liver."
05/01/2014 - "Some variants of the HLA-DP locus (HLA-DPA1 A allele and HLA-DPB1) protect against progression of chronic hepatitis B infection. "
|4.||Acute Disseminated Encephalomyelitis (Postinfectious Encephalomyelitis)
01/01/2012 - "However, as a differentiation between different clinical courses of HBV infection was not possible, knowledge of the HLA-DPA1 genotype cannot be translated into personalized anti-HBV therapy approaches."
01/01/2012 - "A highly significant association of HLA-DPA1 rs3077 with HBV infection was observed in Caucasians. "
01/01/2012 - "The HLA-DPA1 rs3077 C allele was significantly associated with HBV infection (odds ratio, OR = 5.1, 95% confidence interval, CI: 1.9-13.7; p = 0.00093). "
01/01/2012 - "A common HLA-DPA1 variant is associated with hepatitis B virus infection but fails to distinguish active from inactive Caucasian carriers."
04/01/2011 - "HLA - DPA1 rs3077 T was strongly associated with decreased risk of chronic HBV infection (odds ratio, .62; P = .001), consistent with the previous report. "
|1.||HLA-DPB1 (HLA DPB1)
|3.||HLA-DP Antigens (HLA-DP)
|5.||HLA-DRB1 antigen (HLA DRB1)
|6.||Hepatitis B e Antigens
|7.||HLA-DQA1 (HLA DQA1)
|8.||DNA (Deoxyribonucleic Acid)
|9.||human HLA-DQB1 protein